|
WIPF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01839999999232E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.839420E-01 |
| Normal-vs-Stage2 |
8.518900E-03 |
| Normal-vs-Stage3 |
4.3587000009282E-08 |
| Normal-vs-Stage4 |
1.75409999858545E-08 |
| Stage1-vs-Stage2 |
6.557700E-02 |
| Stage1-vs-Stage3 |
3.62499999995158E-06 |
| Stage1-vs-Stage4 |
9.61479999950221E-07 |
| Stage2-vs-Stage3 |
1.518400E-01 |
| Stage2-vs-Stage4 |
4.488100E-02 |
| Stage3-vs-Stage4 |
4.057400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.52160000000446E-05 |
| Normal-vs-AfricanAmerican |
1.000950E-04 |
| Normal-vs-Asian |
6.511000E-01 |
| Caucasian-vs-AfricanAmerican |
3.576100E-02 |
| Caucasian-vs-Asian |
1.412050E-01 |
| AfricanAmerican-vs-Asian |
4.282400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4127000003139E-07 |
| Normal-vs-Female |
9.489800E-02 |
| Male-vs-Female |
1.197000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461750E-02 |
| Normal-vs-Age(41-60Yrs) |
4.803300E-03 |
| Normal-vs-Age(61-80Yrs) |
4.45049999997504E-06 |
| Normal-vs-Age(81-100Yrs) |
1.139610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.990830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.259800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.139000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.019960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.965600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.707000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.570000E-02 |
| Normal-vs-Grade 2 |
6.818000E-02 |
| Normal-vs-Grade 3 |
1.9360799999979E-05 |
| Normal-vs-Grade 4 |
9.33786381551727E-12 |
| Grade 1-vs-Grade 2 |
7.695800E-03 |
| Grade 1-vs-Grade 3 |
6.820200E-04 |
| Grade 1-vs-Grade 4 |
1.52150000043427E-07 |
| Grade 2-vs-Grade 3 |
5.535500E-03 |
| Grade 2-vs-Grade 4 |
2.16659999940916E-08 |
| Grade 3-vs-Grade 4 |
4.555600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.611000E-01 |
| Normal-vs-ccB subtype |
2.9163999992754E-08 |
| ccA subtype-vs-ccB subtype |
1.37949984768682E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.199900E-04 |
| Normal-vs-N1 |
4.726100E-02 |
| N0-vs-N1 |
3.228000E-01 |
|
|
